RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...

RELX PLC (NYSE:RELX) is one of the most profitable industrial stocks to buy now. On June 9, RELX PLC (NYSE:RELX) reiterated ...

OSB Group announces that, as outlined in the announcement of its 2023 Full Year Results on 14 March 2024, it intends to commence, on 15 March 2024, a share repurchase programme to return up to £50 ...

LONDON, UK / ACCESSWIRE / November 1, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company targeting diseases with a high unmet ...

On 10 June 2025 FirstGroup plc (the ‘Group’) announced an on-market share buyback programme to purchase up to £50m of ordinary shares (the ’Programme’), which commenced on 10 June 2025. The Group ...

Announcement of Non-Discretionary Share Buyback Programme and Cancellation of Shares held in Treasury RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that ...

Further to its May 7, 2026 announcement of the start of a $3.0 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’), Shell plc (the ...

LONDON, UK / ACCESSWIRE / June 29, 2023 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent ...